- Record: found
- Abstract: not found
- Article: not found
Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study
D. Zandberg ,
A. Algazi ,
A. Jimeno ,
J.S. Good ,
J. Fayette ,
N. Bouganim ,
N. Ready ,
P.M. Clement ,
T. Goswmi ,
A. Jarkowski ,
J.M. Armstrong ,
K. Asubonteng ,
G. Melillo ,
R. Mesía
September 2017
September 2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.